LifeMD Return On Tangible Equity 2011-2024 | LFMD

LifeMD return on tangible equity from 2011 to 2024. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.

LifeMD Return On Tangible Equity 2011-2024 | LFMD

LifeMD return on tangible equity from 2011 to 2024. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$98.6B
Cencora (COR)$46.2B
DiDi Global (DIDIY)$23.3B
ICON (ICLR)$18.2B
Avantor (AVTR)$15.2B
Natera (NTRA)$14.6B
Revvity (RVTY)$14.3B
Viatris (VTRS)$13.7B
BioMerieux (BMXMF)$13.4B
Solventum (SOLV)$12.6B
CochLear (CHEOY)$12.4B
Medpace Holdings (MEDP)$10.3B
Charles River Laboratories (CRL)$9.4B
Sonic Healthcare (SKHHY)$8.8B
HealthEquity (HQY)$7.7B
Doximity (DOCS)$7.7B
Bausch + Lomb (BLCO)$7.2B
PACS (PACS)$6.4B
Life Times (LTH)$4.7B
Organon (OGN)$4.4B
Sotera Health (SHC)$4.4B
Surgery Partners (SGRY)$3.7B
BrightSpring Health Services (BTSG)$2.7B
Concentras Parent (CON)$2.6B
Ardent Health Partners (ARDT)$2.5B
GoodRx Holdings (GDRX)$2.4B
Alignment Healthcare (ALHC)$2.1B
Premier (PINC)$2B
Ryman Healthcare (RYHTY)$1.9B
GeneDx Holdings (WGS)$1.6B